Eudaimonia Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,336
| Closed | -$1.25M | – | 380 |
|
|
2022
Q4 | $1.25M | Buy |
4,336
+1,871
| +76% | +$540K | 0.31% | 89 |
|
|
2022
Q3 | $714K | Buy |
+2,465
| New | +$714K | 0.19% | 123 |
|
|
2021
Q2 | – | Sell |
-298
| Closed | -$64K | – | 1359 |
|
|
2021
Q1 | $64K | Sell |
298
-12
| -4% | -$2.58K | 0.01% | 576 |
|
|
2020
Q4 | $73K | Sell |
310
-22
| -7% | -$5.18K | 0.02% | 515 |
|
|
2020
Q3 | $90K | Buy |
332
+61
| +23% | +$16.5K | 0.02% | 435 |
|
|
2020
Q2 | $79K | Sell |
271
-83
| -23% | -$24.2K | 0.03% | 412 |
|
|
2020
Q1 | $84K | Buy |
354
+40
| +13% | +$9.49K | 0.04% | 359 |
|
|
2019
Q4 | $69K | Buy |
+314
| New | +$69K | 0.03% | 423 |
|